Biased signaling at neural melanocortin receptors in regulation of energy homeostasis
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, weight management, NEJM 2021), SURMOUNT (tirzepatide, weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide, obstructive sleep apnea, NEJM 2024)
Additionally, researchers also discovered that study participants experienced a drop in their Migraine Disability Assessment Test scores by 32 points
All three medications Wegovy, Mounjaro, and Zepbound have been approved by the FDA to aid in weight loss
Key considerations: Typical concentration: 50 mg per capsule Administration: Swallow whole with water
PT-141 (Bremelanotide) represents a promising new frontier in the treatment of sexual dysfunction, offering an alternative for patients who are unable to use or have not responded to traditional therapies like Viagra